On Friday, Pharnext announced that it had raised 1.3 million euros through the issue of Océanes-BSA subscribed by Global Tech Opportunities 13.

The biopharmaceutical company states that this operation gave rise to the issue of 1.3 million BSAs and will result in the creation of 3.6 million new shares, meaning that the stake of a shareholder holding 1% of the capital prior to this new issue will be reduced to 0.21%.

Prior to this drawdown, the OCEANE-BSA issue had already raised 33.1 million euros, with the potential to create a further 526.3 million new shares.

On this basis, the interest of a shareholder holding 1% of the capital prior to these drawdowns is now less than 0.0008%.

On the stock market, Pharnext shares fell by 14% on Friday, after having soared by more than 400% on Wednesday following the announcement of expressions of interest from potential partners for its lead candidate in Charcot's disease.

Copyright (c) 2023 CercleFinance.com. All rights reserved.